Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹4,209 Cr₹3,743 Cr₹3,341 Cr₹2,890 Cr₹2,588 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹4,209 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹4,209 Cr
Mar2023₹3,743 Cr
Mar2022₹3,341 Cr
Mar2021₹2,890 Cr
Mar2020₹2,588 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2024 ₹4,209 Cr
12.45
Mar2023 ₹3,743 Cr
12.02
Mar2022 ₹3,341 Cr
15.62
Mar2021 ₹2,890 Cr
11.66
Mar2020 ₹2,588 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹31,123.8 Cr -4.8% -2.9% 9.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,188.0 Cr -1.5% 4.6% 3% Stock Analytics
DIVIS LABORATORIES ₹143,074.0 Cr -4.8% -3.2% 40.7% Stock Analytics
CIPLA ₹115,768.0 Cr -1.3% -1.9% -5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,809.0 Cr 1.1% 6.1% 27.1% Stock Analytics
DR REDDYS LABORATORIES ₹92,503.5 Cr -3.6% -2.7% -11.4% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-4.8%

-2.9%

9.5%

SENSEX

-2.4%

0.7%

0.5%


You may also like the below Video Courses